| |
| |
| Acknowledgments | |
| |
| |
| About the Editors | |
| |
| |
| Contributors | |
| |
| |
| Introduction | |
| |
| |
| |
| |
| Overview: Conceptual Issues, Etiology, Epidemiology, and Course | |
| |
| |
| |
| What is Addiction? | |
| |
| |
| |
| |
| Neuroscience of Addiction | |
| |
| |
| |
| |
| Etiology | |
| |
| |
| |
| |
| Epidemiology and Diagnosis | |
| |
| |
| |
| |
| The Course of Treated and Untreated Substance Use Disorders: Remission and Resolution, Relapse and Mortality | |
| |
| |
| |
| |
| Specific Drugs of Abuse: Pharmacological and Clinical Aspects | |
| |
| |
| |
| Alcohol | |
| |
| |
| |
| |
| Sedative-Hypnotic and Anxiolytic Drugs | |
| |
| |
| |
| |
| Amphetamine-Type Stimulants | |
| |
| |
| |
| |
| Cocaine | |
| |
| |
| |
| |
| Cannabis and Hallucinogens | |
| |
| |
| |
| |
| Opioids | |
| |
| |
| |
| |
| Nicotine | |
| |
| |
| |
| |
| Other Drugs of Abuse: Inhalants, Steroids, and Designer Drugs | |
| |
| |
| |
| |
| Case Identification, Assessment, and Treatment Planning | |
| |
| |
| |
| Evidence-Based Assessment: Strategies and Measures in Addictive Behaviors | |
| |
| |
| |
| |
| Treatment Decision Making and Goal Setting | |
| |
| |
| |
| |
| Treatment | |
| |
| |
| |
| Enhancing Motivation for Treatment and Change | |
| |
| |
| |
| |
| Cognitive-Behavioral Treatment for Addictions | |
| |
| |
| |
| |
| Behavioral Treatments | |
| |
| |
| |
| |
| Disease Model Treatments | |
| |
| |
| |
| |
| Couples and Family Treatment Methods | |
| |
| |
| |
| |
| Extended Treatment Models | |
| |
| |
| |
| |
| Mutual-Help Groups for Alcohol and Other Substance Use Disorders | |
| |
| |
| |
| |
| Pharmacotherapies for Alcohol and Drug Use Disorders | |
| |
| |
| |
| |
| Treatment Models for Clients Diverted or Mandated Into Drug Treatment | |
| |
| |
| |
| |
| Mechanisms of Behavior Change in Treatment for Alcohol and Other Drug Use Disorders | |
| |
| |
| |
| |
| Treatment for Substance Use Disorders in the United States: An Organizational Technology Perspective | |
| |
| |
| |
| |
| Practice Issues | |
| |
| |
| |
| Legal and Ethical Issues | |
| |
| |
| |
| |
| Interfaces of Substance Use Treatment With Other Health and Social Systems | |
| |
| |
| |
| |
| Issues in Specific Populations | |
| |
| |
| |
| Treatment of Persons With Substance Use Disorder and Co-Occurring Other Mental Disorders | |
| |
| |
| |
| |
| Treatment for Adolescent Alcohol and Drag Problems | |
| |
| |
| |
| |
| Treatment of Older Adults | |
| |
| |
| |
| |
| Ethnic and Cultural Minority Populations | |
| |
| |
| |
| |
| Women and Addiction | |
| |
| |
| |
| |
| Lesbian, Gay, Bisexual, and Transgender Individuals | |
| |
| |
| |
| |
| Prevention, Policy, and Economics of Substance Use Disorders | |
| |
| |
| |
| Prevention Aimed at Individuals | |
| |
| |
| |
| |
| Prevention Aimed at the Environment | |
| |
| |
| |
| |
| Economic Evaluation of Substance Abuse Interventions: Overview of Recent Research Findings and Policy Implications | |
| |
| |
| |
| |
| National Policy Issues | |
| |
| |
| |
| Index | |